Ingenuity Systems announces Molecule Scientific as exclusive distributor of IPA in Taiwan

NewsGuard 100/100 Score

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced Molecule Scientific Co., Ltd. as the exclusive distributor of IPA® in Taiwan.  

"Molecule Scientific's expertise in life sciences and local presence in Taiwan will facilitate the growing adoption of IPA in Taiwan and the Asia Pacific region," stated Sean Scott, Senior Vice President, Commercial Operations, Ingenuity Systems.  "IPA is currently used at several leading universities in this area and through this partnership we can better address the growing demand from researchers in the Pharmaceutical and Academic environments who request IPA for a wide range of research initiatives including identifying and validating biomarkers, understanding mechanisms behind differential response to drugs, and elucidating biological mechanisms of drug action and toxicity."

Dr. Pei-Li Li, Vice President, Molecule Scientific Co., Ltd., stated, "IPA is a powerful addition to the Molecule Scientific portfolio.  We are pleased to be able to provide our customers with the ability to design their experiments, generate hypotheses, and analyze their data using the detailed, timely, and high-quality information in IPA."

Source:

Ingenuity Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists design breakthrough drug to combat deadly pancreatic cancer mutation